Hasan Çağın Lenk
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 07, 2025
Impact of CYP1A, CYP2C19, CYP2D6, CYP3A4, CYP3A5, and NFIB genotypes on clozapine serum concentration in smokers and nonsmokers.Hasan Çağın Lenk, Line Skute Bråten, Ole A Andreassen
|Sep 19, 2025
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet Insert.Georgios Schoretsanitis, Nermine Laaboub, Séverine Crettol
|Apr 18, 2024
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data.Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell
|Feb 22, 2024
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine.Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset
|Sep 24, 2022
Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits.Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell
|Mar 07, 2022
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.Hasan Çağın Lenk, Katharina Klöditz, Inger Johansson
Pageof 1
Frequent Collaborators
6 joint publications
Espen Molden
4 joint publications
Robert Løvsletten Smith
3 joint publications
Magnus Ingelman-Sundberg
3 joint publications
Kevin S O'Connell
2 joint publications
Marin M Jukić
2 joint publications
Ole A Andreassen
1 joint publications
Katharina Klöditz
1 joint publications
Inger Johansson
1 joint publications
Birgit M Wollmann
1 joint publications
Marianne Kringen Kristiansen
